Verona Pharma (NASDAQ:VRNA) Price Target Raised to $75.00
Verona Pharma (NASDAQ:VRNA – Free Report) had its price objective increased by HC Wainwright from $60.00 to $75.00 in a report issued on Friday,Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Verona Pharma’s Q1 2026 earnings at $0.16 EPS and Q2 2026 earnings at $0.40 […]
Verona Pharma (NASDAQ:VRNA – Free Report) had its price objective increased by HC Wainwright from $60.00 to $75.00 in a report issued on Friday,Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Verona Pharma’s Q1 2026 earnings at $0.16 EPS and Q2 2026 earnings at $0.40 […]
